MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-05-0049477
Epiglue Pharma Private Limited - healthcare in Nsp, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹79.8 Lakh
▲ 186% YoY
Net profit · FY 2024
₹3.67 Lakh
Net margin 4.6%
EBITDA · FY 2024
₹5.6 Lakh
EBITDA margin 7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.33 Lakh
Issued & subscribed
Open charges
₹23 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Epiglue Pharma Private Limited
Data last updated:
Epiglue Pharma Private Limited is a private limited company based in Nsp, Delhi, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 22 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2021PTC388725. Its GSTIN is 06AAGCE7221A1Z7 (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.33 Lakh. It is led by directors Swadha Saraogi and Hemant Saraogi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 108 1st Floor Krishna Apra Business Square Plot No D, 4 – 5&6, Nsp, Delhi, India – 110034.
As per the financials filed for FY 2024, the company reported a revenue of ₹79.8 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.67 Lakh (net margin 4.6%) and EBITDA of ₹5.6 Lakh (EBITDA margin 7%).
The company is associated with 1 brand: Epiglue. As per MCA filings, the company has open charges of ₹23 Lakh on record.
Epiglue Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0049477). For more details, the company can be reached via its website epiglue.com.
Company details
CIN U51909DL2021PTC388725
Registration Number 388725
Incorporation Date 22 October 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-HR-05-0049477
Key People
Swadha Saraogi Director Hemant Saraogi Director Recognitions & Rankings of Epiglue Pharma
Contact details
Epiglue Pharma Private Limited's registered office is in Nsp, Delhi. Its website is epiglue.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit No. 108 1st Floor Krishna Apra Business Square Plot No D, 4 – 5&6, Nsp, Delhi, India – 110034
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Epiglue Pharma Private Limited, buy the company report.
Comprehensive company report
Epiglue Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Epiglue Pharma operates one associated brand: Epiglue. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Medical device for closure of skin wounds using tissue adhesive. | epiglue.com |
Business activity
The main business activity of Epiglue Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Epiglue Pharma Private Limited, buy the company report.
Financials of Epiglue Pharma Private Limited
FY 2025 filings availableEpiglue Pharma Private Limited reported revenue of ₹79.8 Lakh (up 186% YoY) for FY 2024.
Revenue · FY 2024
₹79.8 Lakh ▲ 186%
Net profit · FY 2024
₹3.67 Lakh margin 4.6%
EBITDA · FY 2024
₹5.6 Lakh margin 7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 186%
EBITDA CAGR growth
1 year
▲ 296%
Revenue rose 186% in the latest year. EBITDA rose 296% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹5.6 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹3.67 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 7% | ||
| Net Profit Margin | 4.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Epiglue Pharma Private Limited, buy the company report.
Board of directors of Epiglue Pharma Private Limited
Epiglue Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swadha Saraogi Also directs: Cybergate IT Solutions LLP, Is5.0 Technologies Private Limited | Director | 22 Oct 2021 | 5 Years 0 Months | Current |
| Hemant Saraogi Also directs: Cybergate IT Solutions LLP, Saratthi Mobility Private Limited | Director | 22 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Epiglue Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Medical Consumables), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mahum Surgicot Private Limited | ₹83.18 Lakh (FY 2025) | 27.0% | Udham Singh Nagar, Uttarakhand, India | |||
| Shinkwang Enterprises Private Limited | ₹80.51 Lakh (FY 2025) | -77.0% | New Delhi, Delhi, India | |||
| Salvation Drugs Private Limited | ₹80.06 Lakh (FY 2025) | 12.0% | Allahabad, Uttar Pradesh, India | |||
| Epiglue Pharma Private Limitedthis company | ₹79.8 Lakh (FY 2024) | ₹3.67 Lakh | 4.6% | 186.0% | Nsp, Delhi, India | |
| Curosil Lifecare Private Limited | ₹79 Lakh (FY 2025) | 67.0% | Surat, Gujarat, India |
To see the full peer comparison of Epiglue Pharma Private Limited, buy the company report.
Auditor
Epiglue Pharma Private Limited is audited by Anubhav Kushwaha And Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Anubhav Kushwaha And Associates | FY 2022 | 530225 |
Shareholding
The shareholding of Epiglue Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Epiglue Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹23 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Apr 2024 | 100926840 | Others | ₹15 Lakh | Open | |
| 13 Nov 2023 | 100824362 | Others | ₹8 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Epiglue Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Epiglue Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Epiglue Pharma Private Limited has 1 active EPFO establishment as of Apr 04, 2024.
Active EPFO establishments
1
GST
Epiglue Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAGCE7221A1Z7 | Haryana | Active | 17 Jun 2022 |
To see the full GST registrations and return filing status of Epiglue Pharma Private Limited, buy the company report.
Recent activity
Epiglue Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Hemant Saraogi was appointed as Director on 22 Oct 2021.
AGM
Epiglue Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Epiglue Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 15.00 Lakh with Charge ID 100926840 was registered on 26 Apr 2024.
Charges
A charge with Others amounted to Rs. 8.00 Lakh with Charge ID 100824362 was registered on 13 Nov 2023.
Appointed
Hemant Saraogi was appointed as Director.
Appointed
Swadha Saraogi was appointed as Director.
Incorporation
22 Oct 2021
Epiglue Pharma Private Limited was registered on 22 Oct 2021 with Roc Delhi & aged 5 years 8 days as per MCA records.
Frequently asked questions
Epiglue Pharma is an active private limited company based in Nsp, Delhi, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 22 October 2021 (5+ years old) and is registered under CIN U51909DL2021PTC388725.
Epiglue Pharma has 2 current directors:
- Swadha Saraogi - Director
- Hemant Saraogi - Director
The latest financial statements of Epiglue Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Epiglue Pharma is 06AAGCE7221A1Z7, registered in Haryana.
The CIN (Corporate Identification Number) of Epiglue Pharma is U51909DL2021PTC388725. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Epiglue Pharma was incorporated on 22 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Epiglue Pharma by revenue are Mahum Surgicot Private Limited, Shinkwang Enterprises Private Limited, Salvation Drugs Private Limited, Curosil Lifecare Private Limited, all in the Healthcare industry (Medical Consumables), with the same principal business activity (wholesale trading).
Hemant Saraogi was appointed as Director on 22 Oct 2021. Swadha Saraogi was appointed as Director on 22 Oct 2021.
Yes, Epiglue Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-05-0049477).
Epiglue Pharma can be reached through the website epiglue.com. Its registered office is in Nsp, Delhi, India.
The registered office of Epiglue Pharma is at Unit No. 108 1st Floor Krishna Apra Business Square Plot No D, 4 – 5&6, Nsp, Delhi, India – 110034.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages